Inventor
KAPA PRASAD K
US15 patents
⚠️ This page may combine multiple inventors who share the name “KAPA PRASAD K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANDOZ LTD
8 patentsUS5290946AMar 1, 1994
Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
SANDOZ LTD90 citations94
US5189164AFeb 23, 1993
Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof
SANDOZ LTD112 citations94
US5412137AMay 2, 1995
Process for preparing phosphinyloxy propanaminium inner salt derivatives
SANDOZ LTD36 citations92
US5208352AMay 4, 1993
Process for preparing the R- and S-isomers of 2-hydroxy-methyl-2-octadecyloxymethyl-tetrahydrofuran and their use in preparing stereoisomers of pharmacologically active compounds
SANDOZ LTD7 citations72
US5596094AJan 21, 1997
Process for preparing 2' -0- alkyl adenosine derivatives
SANDOZ LTD6 citations62
US5319123AJun 7, 1994
Process for preparing substituted N-oxy-imidic acid derivatives
SANDOZ LTD1 citations50
US5338730AAug 16, 1994
Use of the (R) isomer of 2-[(2-octa-decyloxymethyl-tetrahydro-2-furanylmethoxy)-hydroxyphosphinyloxy]-N,N,N-trimethylethanaminium hydroxide inner salt-4-oxide in treating multiple sclerosis
SANDOZ LTD0 citations45
US5229377AJul 20, 1993
Process for the preparation of the (R) stereoisomer of the monobutyric ester of 2,2-bis(hydroxymethyl)-tetrahydrofuran, its use in preparing stereoisomers of pharmacologically active compounds, and certain specific stereoisomers produced thereby
SANDOZ LTD1 citations45
SANDOZ PHARMACEUTICALS CORP
3 patentsUS4870199ASep 26, 1989
Processes for the synthesis of diprotected R[R*,S*]-3,5-dihydroxy-6-oxohexanoate esters
SANDOZ PHARMACEUTICALS CORP18 citations72
US4847384AJul 11, 1989
Process for the preparation of certain nitrogen-containing mono- and bicyclic ace inhibitors, and novel intermediates useful therefor
SANDOZ PHARMACEUTICALS CORP5 citations60
US4841071AJun 20, 1989
6-substituted-4-hydroxy-tetrahydropyran-2-ones
SANDOZ PHARMACEUTICALS CORP0 citations51